The pharmacological significance of protein-protein interactions

被引：0

作者：

Barnes, NM ^{[1
]}

Brady, CA ^{[1
]}

Dawlatly, S ^{[1
]}

Lin, L ^{[1
]}

Williams, JM ^{[1
]}

Hope, AG ^{[1
]}

机构：

[1] Univ Birmingham, Sch Med, Dept Pharmacol, Birmingham BIS 2TT, W Midlands, England

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

263P

引用

页码：U135 / U135

页数：1

共 50 条

[31] Interrupting protein-protein interactions
Gitig, Diana
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (11): : 44 - 45
[32] Inhibiting protein-protein interactions
Morrow, K. John, Jr.
GENETIC ENGINEERING NEWS, 2006, 26 (10): : 1 - +
[33] Unraveling protein-protein interactions
Pray, L
SCIENTIST, 2003, 17 (02): : 34 - 36
[34] Screening for protein-protein interactions
Germino, FJ
Moskowitz, NK
CDNA PREPARATION AND CHARACTERIZATION, 1999, 303 : 422 - 450
[35] Principles of protein-protein interactions
Teichmann, SA
BIOINFORMATICS, 2002, 18 : S249 - S249
[36] Cooperativity in protein-protein interactions
Brunsveld, L.
FEBS OPEN BIO, 2022, 12 : 266 - 266
[37] Characterizing Protein-Protein Interactions
Larkin, Michael I.
Hanlon, Amy D.
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2011, 31 (09): : 24 - 25
[38] Inhibitors of protein-protein interactions
Ockey, DA
Gadek, TR
EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (03) : 393 - 400
[39] Protein-protein interactions for therapeutics
Pearson, S
GENETIC ENGINEERING NEWS, 2002, 22 (19): : 12 - +
[40] Protein-Protein Interactions of Phosphodiesterases
Al-Nema, Mayasah Y.
Gaurav, Anand
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (07) : 555 - 564